Literature DB >> 24739898

Anti-androgen monotherapy for metastatic prostate cancer.

Gerhardt Attard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24739898     DOI： 10.1016/S1470-2045(14)70159-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Dietary Tomato or Lycopene Do Not Reduce Castration-Resistant Prostate Cancer Progression in a Murine Model.

Authors:  Joe L Rowles; Joshua W Smith; Catherine C Applegate; Rita J Miller; Matthew A Wallig; Amandeep Kaur; Jesus N Sarol; Salma Musaad; Steven K Clinton; William D O'Brien; John W Erdman
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

Review 2.  Management of metastatic hormone-sensitive prostate cancer.

Authors:  Brandon Bernard; Christopher J Sweeney
Journal:  Curr Urol Rep       Date:  2015-03       Impact factor: 3.092

3.  Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.

Authors:  Yanlong Zhang; Ruiqiao Zhang; Fangzhi Liang; Liyun Zhang; Xuezhi Liang
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

4.  DNA Methylation Modification Regulator-Mediated Molecular Clusters and Tumor Metabolic Characterization in Prostate Cancer.

Authors:  Yanlong Zhang; Xuezhi Liang; Liyun Zhang; Dongwen Wang
Journal:  J Oncol       Date:  2021-11-11       Impact factor: 4.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.